CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 95 filers reported holding CYTOSORBENTS CORP in Q4 2020. The put-call ratio across all filers is 1.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $70,000 | -93.1% | 22,524 | -80.9% | 0.00% | – |
| Q3 2021 | $1,010,000 | +6633.3% | 117,966 | +6847.3% | 0.00% | – |
| Q1 2021 | $15,000 | -75.8% | 1,698 | -75.4% | 0.00% | – |
| Q4 2020 | $62,000 | +226.3% | 6,898 | +184.1% | 0.00% | – |
| Q3 2020 | $19,000 | -42.4% | 2,428 | -25.9% | 0.00% | – |
| Q2 2020 | $33,000 | +725.0% | 3,278 | +528.0% | 0.00% | – |
| Q1 2020 | $4,000 | -76.5% | 522 | -88.3% | 0.00% | – |
| Q4 2019 | $17,000 | +21.4% | 4,476 | +66.7% | 0.00% | – |
| Q3 2019 | $14,000 | -17.6% | 2,685 | +6.5% | 0.00% | – |
| Q2 2019 | $17,000 | +325.0% | 2,521 | +480.9% | 0.00% | – |
| Q4 2018 | $4,000 | -55.6% | 434 | -35.4% | 0.00% | – |
| Q3 2018 | $9,000 | +350.0% | 672 | +232.7% | 0.00% | – |
| Q2 2018 | $2,000 | -99.3% | 202 | -99.6% | 0.00% | – |
| Q4 2015 | $306,000 | – | 54,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 450,000 | $846,000 | 0.90% |
| Skylands Capital, LLC | 2,944,670 | $5,535,980 | 0.84% |
| Sargent Investment Group, LLC | 1,257,048 | $2,363,250 | 0.57% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 197,940 | $372,127 | 0.52% |
| Avenir Corp | 2,717,397 | $5,108,706 | 0.48% |
| Granahan Investment Management | 1,552,393 | $2,918,499 | 0.10% |
| Seelaus Asset Management LLC | 20,450 | $38,446 | 0.04% |
| HighMark Wealth Management LLC | 10,000 | $18,800 | 0.02% |
| Key Client Fiduciary Advisors, LLC | 13,000 | $24,440 | 0.02% |
| Eudaimonia Partners, LLC | 23,500 | $44,180 | 0.01% |